IBBJ
Defiance Nasdaq Junior Biotechnology ETF$29.87— (—)AUM $8.2MER 0.45%NAV $29.93Holdings 3Inception Aug 2020
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
2.4KDividend Yield
—Expense Ratio
0.45%AUM
$8.2MShares Outstanding
—ETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Category
- Healthcare
- Inception Date
- Aug 3, 2020
- Description
- The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.
Similar ETFs
The Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is an exchange-traded fund that launched on Aug 3, 2020. It currently manages $8.2M in assets under management. The fund charges an expense ratio of 0.45%. The fund holds 3 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Cash&Other | Cash & Other | 99.91% | 7,475,541 | $7.5M |
| 2 | PDLI | PDL BIOPHARMA INC | 0.09% | 2,625 | $6K |
| 3 | 761CVR026 | CONTRA RESTORBIO INC | 0.00% | 43 | $0 |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | — | |
| 5Y | -8.40% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$29.87
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | IBBJ | Healthcare(174 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.45% | 0.60% | 0.83% |
| AUM | $8.2M | $875.8M | $1.50B |
| Dividend Yield | — | 3.42% | 1.97% |
| Avg Volume | 2.4K | 270.2K | 855.6K |
| Holdings | 3 | 89 | 65 |
| Performance | |||
| 1-Month Return | — | +2.02% | +4.91% |
| 6-Month Return | — | +3.84% | +6.08% |
| YTD Return | — | +3.23% | +6.19% |
| 1-Year Return | — | +23.91% | +35.54% |
Compare with Another ETF
Search for an ETF to compare with IBBJ:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.